Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer
Clinical trial NCT06487429 · RECRUITING
Trial details
- NCT number
- NCT06487429
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-08
- Primary completion
- 2026-05-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.